Vir Biotechnology
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company based in San Francisco, California. Founded in 2017, the company focuses on developing innovative medicines that harness the human immune system to tackle significant unmet medical needs, particularly in infectious diseases and oncology. Vir aims to create a world without infectious disease by utilizing advanced biological tools, including next-generation antibody engineering and its proprietary PRO-XTEN™ technology. The company develops antibody-based therapies and protease-releasable masked therapeutics targeting various conditions, including chronic hepatitis delta, hepatitis B, and solid tumors. Vir has advanced multiple drug candidates into clinical trials for diseases such as COVID-19, Ebola, and tuberculosis. With a dedicated workforce of over 200 employees, Vir is committed to improving patient outcomes globally by addressing critical health challenges through its innovative therapeutic programs.
Work at Vir Biotechnology in HR or recruiting? Claim this page
Headcount trend
Vir Biotechnology went from 521 employees in Jul 2023 to 388 in Jun 2025. Jan to Jun 2025: 13 people joined, 23 left.
Headcount data through Jun 2025
Org structure
Headcount by department
Executive compensation
Hiring now
See all jobsSalaries at Vir Biotechnology
All salaries1 salary profiles in the US
H-1B sponsorship
The department split adds up all the years listed above. FY2026 alone: 2 filings.
Peer reviews
Worked with someone at Vir Biotechnology?
Anonymous peer reviews on OffTheRecord
Similar companies
Vir Biotechnology FAQ
How many employees does Vir Biotechnology have?
Vir Biotechnology has about 388 employees, down 1.5% over the 3 months to Jun 2025.
Does Vir Biotechnology sponsor H1B visas?
Yes. Vir Biotechnology filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
What is Vir Biotechnology's revenue per employee?
Vir Biotechnology makes about $48K in revenue per employee, based on $18.53M annual revenue and 388 employees.
How much does Vir Biotechnology pay?
6figr has 1 salary profile for Vir Biotechnology in the US, with pay broken down by role, level, gender and ethnicity on the Vir Biotechnology salaries page. See Vir Biotechnology salaries
Is Vir Biotechnology a public company?
Yes. Vir Biotechnology is publicly traded under the ticker VIR on NASDAQ.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.
